Marcelo Gottschalk (University or college of Montreal) for his generous gift of reference antisera againstS

Marcelo Gottschalk (University or college of Montreal) for his generous gift of reference antisera againstS

Marcelo Gottschalk (University or college of Montreal) for his generous gift of reference antisera againstS.suisand his constructive comments, and Dr. from your wild-type mice sera experienced no effect on bacterial killing by opsonophagocytosisin vitro. Somatic hypermutation and isotype switching were dispensable for controlling the infection or anti-CPS IgM production. However, T cell-deficient (Tcrb-/-) mice were unable to control bacteremia, produce optimal anti-CPS IgM titers, or elicit antibodies with opsonophagocytic activity. SAP deficiency, which prevents GC formation but not extrafollicular B cell responses, ablated antiS.suis-IgG production but maintained IgM production THAL-SNS-032 and eliminated the infection. In contrast, B cell deficient mice were unable to control bacteremia. Collectively, our results indicate that this antibody response plays a large role in immunity againstS.suis, with GC-independent but T cell-dependent germline IgM being the major effective antibody specificities. Our results further spotlight the importance IgM, and potentially anti-CPS antibodies, in clearingS.suisinfections and provide insight for future development ofS.suisvaccines. == Author summary == Streptococcus suisis an important bacterial pathogen that affects swine and can cause severe infections in humans. To date, there is no efficacious vaccine commercially available to preventS.suisinfections. To make it worse, little is known on how the bacterium interacts with B cells, which are the cells that produce protective antibodies. In this work, we sought to better understand how antibodies are produced following infection, what is their specific targets and which antibodies play an important role in the removal of the bacteria. To do so, we first performed contamination and immunisation trials in mice to characterize how the antibody response evolves. Following this, we tested mice of various genetic profiles to evaluate the role of important genes and cell types in the production of useful antibodies. The results obtained in this study indicate that IgM antibodies, such as the ones able to target the protective shell of the bacteria, play an important role inS.suiselimination. The acquired knowledge in Rabbit Polyclonal to MAP3K7 (phospho-Thr187) this study provides a better understanding of how the immune response evolves againstS.suisand brings insight for future development of vaccines againstS.suis. == Introduction == Streptococcus suisis one of the most important bacterial pathogens in swine production worldwide [1], responsible of heavy economic losses for the industry and causing severe health conditions such as septicemia, meningitis, and death of affected pigs [2].S.suisis also a zoonotic agent that can represent a health risk for the workers of the swine industry [3]. Human contamination usually prospects to the development of septicemia, meningitis, and other severe systemic diseases. Deadly outbreaks in Asia caused by particularly virulent strains have been reported in the past [1]. S.suisis a Gram-positive bacterium, that mainly colonizes the upper respiratory tract of swine, particularly the tonsils [4].S.suisclassification into 29 distinct serotypes is based on the antigenic diversity of the thick capsular polysaccharide (CPS) that surrounds the bacterium [5]. Of all the serotypes described, the serotype 2 is the most clinically THAL-SNS-032 important in both pigs and humans [1]. Transmission of bacteria is done vertically when piglets get in contact with the contaminated vaginal secretions from your sow and, horizontally in the herd via aerosols and direct contact [4]. Transmission of new virulent strains to the farm can occur via the introduction of healthy service providers to the herd [6]. Horizontal transfer is usually exacerbated during outbreaks where diseased animals shed higher amounts of bacteria [2]. In humans, the main reported route of entry is usually via small skin wounds and, in some Asian countries, via consumption of natural or undercooked contaminated pork products [3]. Prevention and treatment ofS. suisinfections greatly relies on the use of antimicrobials. The rise of antimicrobial resistances inS.suisis alarming [7] and this bacterium represents a high risk of transferring resistances to other animal and human pathogens [8]. Vaccination is usually a powerful tool to prevent infections and reduce antimicrobial use. However, no efficient universal vaccine is usually commercially available to preventS. suisinfections despite of several studies and trials exploring many potential candidate antigens [911]. Multiple factors are responsible for this, such as the high genomic diversity between strains and the presence of multiple serotypes. The lack of fundamental knowledge THAL-SNS-032 around the adaptive immune response induced byS.suisinfection adds to the challenge of developing an efficacious vaccine. Immune evasion capabilities have been attributed to THAL-SNS-032 the virulence factors ofS.suis[12]. From this arsenal, the solid CPS is usually widely recognized as the most important virulence factor that allows bacterial evasion of the host immune system and favors bloodstream dissemination by interfering withS.suisphagocytosis and killing by host phagocytes [12,13]. Indeed, it has been demonstrated that this CPS ofS.suisserotype 2 hinders phagocytosis and cytokine release mediated by dendritic cells (DC) [14] and affects optimal T cell activation [15] allowing the bacteria to interfere with proper antigen presentation and downstream main and memory responses of T cells. Studies onS.suis, other streptococci and encapsulated bacteria have.